Award recordCONTRACT

VITALANT

PIID 36C26122N0033· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2022· $562,753 net obligations· UEI GKT4L2JZJ622· AZ

Description

BLOOD AND BLOOD PRODUCTS

First action · last action
2021-10-01 · 2023-03-24
Transactions
2
First transaction's obligation
$796,796
Base + all options value (sum of deltas)
$562,753
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA26117G0047
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$796,796$0Base award · 2021-10-01 · this action $796,796 · running total $796,796Modification P00001 · 2023-03-24 · this action -$234,043 · running total $562,753
  • Base2021-10-01+$796,796= $796,796
  • Mod P000012023-03-24-$234,043= $562,753
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-01+$796,796$796,796BLOOD AND BLOOD PRODUCTS
Mod P00001· FUNDING ONLY ACTION2023-03-24−$234,043$562,753BLOOD AND BLOOD PRODUCTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GKT4L2JZJ622)

AwardOffice · PSC / listingNet obligationsFY
36C26026D0056260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY$0FY2026
36C26026N0391260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY$70,000FY2026
36C24426N0344244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS$1,682,246FY2026
36C24426D0025244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS$0FY2026
36C24426N0788244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER$56,268FY2026
36C26126N0359261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$123,337FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122N0033_3600_VA26117G0047_3600 · retrieved 2026-09-26.